This document summarizes a presentation on building lasting patient relationships through dispensaries. It discusses how dispensaries can be viewed not just for profitability but also for building the practice brand and loyalty. It outlines factors like frequent, meaningful interactions that build trust with patients. The presentation covers topics like defining objectives, mapping opportunities to strengthen relationships and improve outcomes, and using a measurement framework to assess performance. It emphasizes an expanded view of dispensaries as integral to the patient experience and relationship with the practice.
Placing Customer Centricity at the Heart of Healthcare1to1 Media
A look at how healthcare providers, pharmaceuticals, and health insurers are adapting to the changing customer landscape and evolving their patient experiences. www.1to1media.com
"Differentiating the generics in emerging markets"Ferudun Kandemir
How are generic products perceived in emerging markets?
What are the key points in order to create a good product strategy?
What is customer oriented contextual segmentation?
How do you examine current dynamics to create preferable generics in emerging markets?
Making the Shift: Healthcare's Transformation to Consumer-CentricityProphet
In our latest report, “Making the Shift: Healthcare’s Transformation to Consumer-Centricity” Prophet interviewed more than 50 executives across the U.S., Europe and Asia, from healthcare organizations including hospital systems, payers, pharmaceutical companies and digital health companies to identify the five keys shifts that healthcare organizations need to make to become more consumer-centric.
Learn key findings from each of the five shifts including the challenges and solutions organizations face to become more consumer-centric.
Six marketing strategies for Ambulatory Surgery Centers sponsored by Healthcare Pioneers™ - a healthcare innovation network of 30,000 entrepreneurs and executives in the healthcare industry.
This answers questions about why customers behave the way they do in in pharmacy settings. Although it might appear irrational at times, they act in ways that are consistent with consumer behavior theories.
Adding value and patient-centric services and innovation in pharmaplanetkatara
Umamiflow/Katara, VAST Health and the Antwerp Management School (AMS) collaborated on 3 scientific questions: challenges for innovation implementation, a good innovation scan and the service model as alternative for pharmaceutical companies. The analysis was fed by both pharmaceutical companies and patient organizations. Are they ready to go from cure to care?
Placing Customer Centricity at the Heart of Healthcare1to1 Media
A look at how healthcare providers, pharmaceuticals, and health insurers are adapting to the changing customer landscape and evolving their patient experiences. www.1to1media.com
"Differentiating the generics in emerging markets"Ferudun Kandemir
How are generic products perceived in emerging markets?
What are the key points in order to create a good product strategy?
What is customer oriented contextual segmentation?
How do you examine current dynamics to create preferable generics in emerging markets?
Making the Shift: Healthcare's Transformation to Consumer-CentricityProphet
In our latest report, “Making the Shift: Healthcare’s Transformation to Consumer-Centricity” Prophet interviewed more than 50 executives across the U.S., Europe and Asia, from healthcare organizations including hospital systems, payers, pharmaceutical companies and digital health companies to identify the five keys shifts that healthcare organizations need to make to become more consumer-centric.
Learn key findings from each of the five shifts including the challenges and solutions organizations face to become more consumer-centric.
Six marketing strategies for Ambulatory Surgery Centers sponsored by Healthcare Pioneers™ - a healthcare innovation network of 30,000 entrepreneurs and executives in the healthcare industry.
This answers questions about why customers behave the way they do in in pharmacy settings. Although it might appear irrational at times, they act in ways that are consistent with consumer behavior theories.
Adding value and patient-centric services and innovation in pharmaplanetkatara
Umamiflow/Katara, VAST Health and the Antwerp Management School (AMS) collaborated on 3 scientific questions: challenges for innovation implementation, a good innovation scan and the service model as alternative for pharmaceutical companies. The analysis was fed by both pharmaceutical companies and patient organizations. Are they ready to go from cure to care?
Tom Krohn, Business Lead for the Lilly Clinical Open Innovation Team, gave this presentation at the Patients at the Center of Clinical Research Workshop on Nov. 14, 2013.
In it, he discusses ways in which patients can become collaborators in drug development
The new pharma, customer centric, databased business modelA.R.J. (Rob) Halkes
Customer focus is the core and the basis for all commercial activities for pharma. Customers, physicians and patients expect effective therapies in drugs and support. Sustainable relations with customers are necessary to build trusted relations to create a cooperation to realize that. This tells you how to!
The differentiation pharma needs in marketing in the advanced markets, Rob Ha...A.R.J. (Rob) Halkes
What differentiation in market approach must pharma be able to do in advanced markets.
How to perform them?
What changes to business?
Rob Halkes, October 2009.
Defining your role in patient experience aamc-gia presesentationEndeavor Management
Want to learn how marketing gains a seat at the table in the patient experience? This presentation with MD Anderson and Vanderbilt provides some great tips.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Brand Differentiation in the Pharmaceutical Industry: Interview with: Robert Finkel, Principal & Chief Creative Officer, Kane & Finkel Healthcare Communications, a sponsor company at the marcus evans PharmaBrand Summit 2012, on differentiating brands in the highly restricted pharmaceuticals industry.
The World Congress Summit on Patient Solution Services and Hub Design WorldCongress
Due to elevated needs for value-based and cost-effective treatments, bio/pharma has the opportunity to implement patient assistance and hub programs to support the patient journey. Assess strategies to ensure effective patient adherence, customer satisfaction, brand loyalty, and additional prescriber touch points by navigating reimbursement programs.
Understand ACA implications on opportunities and challenges of patient solution services.
Integrate support with nonprofit patient organizations and copay assistance foundations.
Break down regulatory barriers to successful patient engagement.
Benchmark metrics for successful Hubs: Optimize the right Hub design to fit portfolio needs.
Improve speed to therapy through new technologies.
http://www.worldcongress.com/events/PB14011/
Building your life sciences business in Europe, North America and Internationally
The Solution
Bridgehead provides a coordinated, professionally managed strategy to retain value, whilst minimising risk. Bridgehead is the only Boston, London and Zug based group providing an integrated healthcare solution for launch into European and US markets. Bridgehead coordinates proven, experienced, Professional service providers, who have US and European experience in all of the essential launch and support components.
Enabling Patient Centricity for Pfizer through AWS Cloud (LFS301-S-i) - AWS r...Amazon Web Services
Pfizer needed the ability to perform rapid analysis on its set of real-world evidence (RWE) data to improve patient outcomes, but its existing platform could not scale and meet its objectives. Pfizer collaborated with Deloitte to transform its real-world data and analytics capabilities that maximize insights and avoid duplicative investments by migrating their existing RWE data and analytics environment to the AWS Cloud. Learn how these strategies for planning, executing, and validating the success of these capabilities helped position Pfizer to use the AWS Cloud environment as the cornerstone of its patient-centric analytics to expand and incorporate new AI/ML capabilities, such as Amazon SageMaker. This session is brought to you by AWS partner, Deloitte Consulting LLP.
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
A short window of opportunity exists for pharmaceutical companies to establish indispensable beyond the pill services, which may even help them 'own' particular disease areas.
Good service design can be a source of competitive advantage for pharmacists. This presentation describes how pharmacists can design better service experiences for patients.
Tom Krohn, Business Lead for the Lilly Clinical Open Innovation Team, gave this presentation at the Patients at the Center of Clinical Research Workshop on Nov. 14, 2013.
In it, he discusses ways in which patients can become collaborators in drug development
The new pharma, customer centric, databased business modelA.R.J. (Rob) Halkes
Customer focus is the core and the basis for all commercial activities for pharma. Customers, physicians and patients expect effective therapies in drugs and support. Sustainable relations with customers are necessary to build trusted relations to create a cooperation to realize that. This tells you how to!
The differentiation pharma needs in marketing in the advanced markets, Rob Ha...A.R.J. (Rob) Halkes
What differentiation in market approach must pharma be able to do in advanced markets.
How to perform them?
What changes to business?
Rob Halkes, October 2009.
Defining your role in patient experience aamc-gia presesentationEndeavor Management
Want to learn how marketing gains a seat at the table in the patient experience? This presentation with MD Anderson and Vanderbilt provides some great tips.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Brand Differentiation in the Pharmaceutical Industry: Interview with: Robert Finkel, Principal & Chief Creative Officer, Kane & Finkel Healthcare Communications, a sponsor company at the marcus evans PharmaBrand Summit 2012, on differentiating brands in the highly restricted pharmaceuticals industry.
The World Congress Summit on Patient Solution Services and Hub Design WorldCongress
Due to elevated needs for value-based and cost-effective treatments, bio/pharma has the opportunity to implement patient assistance and hub programs to support the patient journey. Assess strategies to ensure effective patient adherence, customer satisfaction, brand loyalty, and additional prescriber touch points by navigating reimbursement programs.
Understand ACA implications on opportunities and challenges of patient solution services.
Integrate support with nonprofit patient organizations and copay assistance foundations.
Break down regulatory barriers to successful patient engagement.
Benchmark metrics for successful Hubs: Optimize the right Hub design to fit portfolio needs.
Improve speed to therapy through new technologies.
http://www.worldcongress.com/events/PB14011/
Building your life sciences business in Europe, North America and Internationally
The Solution
Bridgehead provides a coordinated, professionally managed strategy to retain value, whilst minimising risk. Bridgehead is the only Boston, London and Zug based group providing an integrated healthcare solution for launch into European and US markets. Bridgehead coordinates proven, experienced, Professional service providers, who have US and European experience in all of the essential launch and support components.
Enabling Patient Centricity for Pfizer through AWS Cloud (LFS301-S-i) - AWS r...Amazon Web Services
Pfizer needed the ability to perform rapid analysis on its set of real-world evidence (RWE) data to improve patient outcomes, but its existing platform could not scale and meet its objectives. Pfizer collaborated with Deloitte to transform its real-world data and analytics capabilities that maximize insights and avoid duplicative investments by migrating their existing RWE data and analytics environment to the AWS Cloud. Learn how these strategies for planning, executing, and validating the success of these capabilities helped position Pfizer to use the AWS Cloud environment as the cornerstone of its patient-centric analytics to expand and incorporate new AI/ML capabilities, such as Amazon SageMaker. This session is brought to you by AWS partner, Deloitte Consulting LLP.
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
A short window of opportunity exists for pharmaceutical companies to establish indispensable beyond the pill services, which may even help them 'own' particular disease areas.
Good service design can be a source of competitive advantage for pharmacists. This presentation describes how pharmacists can design better service experiences for patients.
2013 10 utilizing member engagement to improve cahps scoresimagine.GO
The Accountable Care Act means more access to healthcare for more people. But to pay for that access it also means margins for healthcare companies are going to be squeezed. But this does not necessarily imply doom for healthcare companies. The law actually encourages healthcare businesses to build better business models – and is willing to pay for it. By retooling your market approach, and the operations that run your business, you can actually improve your margins and your customer’s happiness at the same time you are helping to create a better and more efficient healthcare ecosystem.
How to Assess the ROI of Your Population Health InitiativeHealth Catalyst
In the brave new world of value-based healthcare, investing in population health management (PHM) is a requirement for success. Defining PHM isn’t easy, but there is one common term that appears among all the diverse interpretations—outcomes. Assessing the potential ROI for investments in PHM using a clear, understandable framework, can help organizations methodically identify and prioritize their PHM investments. While not every PHM intervention makes sense for every situation, it is important to determine which programs provide the most benefit, as well as determining when the investment will begin paying dividends, to achieve success in the era of PHM.
Patient Loyalty: What it Takes to Earn Their Loyalty Sallie Burnett
Patient Loyalty Is Up for Grabs
Recent research showed consumers are just as likely to switch healthcare providers as hotels if they don’t get responsiveness and convenience. In fact, 61% would switch providers to get an appointment quickly. 52% would switch to get an appointment at a convenient location.
Those healthcare providers that develop strategies, capabilities and analytics to enable the key elements of a superior patient experience—speed to access, convenience, information transparency and personalized service— will be best positioned to outperform their peers.
This presentation gives you insight into the current healthcare marketplace and seven best practices for building patient loyalty.
This is my capstone at Emerson College from January to April 2014. I was the Account Manage in the team of six. The client is OBP Medical. The slides do not include the opening video, agency profile video and commercial.
AMA Houston Healthcare SIG: Health Reform and Brand ManagementEndeavor Management
John McKeever recently spoke to the AMA Houston's Healthcare Special Interest Group (SIG) and shared how to effectively manage one's brand while navigating health reform.
describe about pharmaceutical marketing in digital era, how pharmaceutical industry development, hows the marketing and explain about promotional tools that use to develop the pharmaceutical marketing. this presentation also describe how research on sample use. direct to consumer (DTC) strategy, recomendation and distributuion models
Presentation to HIMSS Summit of the Southeast 09.17.14Michael Burcham
Presentation on Disruption | Emerging Buisness Models in Healthcare - Presented at the HIMSS Summit of the Southeast in Nashville, TN on 09.17.14. The presentation underscores the significant opportunities that exist in healthcare for entrepreneurs, investors, and strategic partners.
Managing Partner at The Brytemoore Group
Everyone has a lens. My specialty is Operational Branding.
Go through quickly. Discuss.
No right answer, but you should be thinking about the answer to this question
For many of you, the answer to it may be surprising.
What the patient sees/senses right now is likely driven by your investment in the up-front and the visit itself.
Upwards of 50% of your revenue comes from dispensary sales
Whether your response is “there’s room for me to grow the amount people spend on me per month” or “I can get the same result but spend less by focusing on key experiences” or “I’ve never thought of using my dispensary as a WOM tool”
There is an opportunity here.
As an easy proof point, think about the % of your patients who order a maintenance-type supplement – e.g., multi-vitamins, fish oils. 25%? What would happen if you increased that to 30%. If you have 1,000 patient base, that’s $20*50*12=$12k/yr
And this is the idea that I want you to walk away with: it’s consistent, compelling experiences that drive your patients’ perceptions of your clinic.
Your dispensary is a significant opportunity to do this on an ongoing basis
If you stop thinking about the experience and your interactions at the handoff to front desk after your first visit, you’ve lost an opportunity.
So that was a good presentation, right?
But here’s why you actually care.
Whether you’re looking to grow the business or expand the impact you have on people’s health, the health of your brand is critical
We know that “healthier brands” are ones that people want to engage with, talk about, use more frequently, associate with
There’s an old saying that we do business with people we like. Same thing’s true of brands. Vital brands simply do better in the market.
So the question is what is brand health?
You all spend your time thinking about individual and public health
And you know that you can measure it by specific markers
But the reality is that like people, there’s not a single answer. What you’re looking for is a process of discovery; a way that you can help your brand more closely resemble its best self.
So why do you care about this?
Because your patients do.
And because supplements and wellness and treatment options are going to become an even bigger discussion topic.
So where to start?
There are three questions that should give you some insight.
And when you get through asking them, you may have more of a sense of where you stand in the evolution of a practice